NBW Capital LLC Reduces Position in HealthEquity, Inc. (NASDAQ:HQY)

NBW Capital LLC lessened its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 0.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,391 shares of the company’s stock after selling 224 shares during the period. HealthEquity accounts for approximately 1.4% of NBW Capital LLC’s investment portfolio, making the stock its 27th biggest position. NBW Capital LLC owned about 0.10% of HealthEquity worth $7,052,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of HQY. Vanguard Group Inc. grew its stake in shares of HealthEquity by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock valued at $715,783,000 after buying an additional 149,133 shares during the period. Wasatch Advisors LP grew its stake in shares of HealthEquity by 8.3% in the 1st quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after buying an additional 569,249 shares during the period. Motley Fool Asset Management LLC grew its stake in shares of HealthEquity by 3,001.0% in the 1st quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after buying an additional 3,640,748 shares during the period. Clearbridge Investments LLC grew its stake in shares of HealthEquity by 6.9% in the 4th quarter. Clearbridge Investments LLC now owns 2,357,572 shares of the company’s stock valued at $156,307,000 after buying an additional 152,897 shares during the period. Finally, Mackenzie Financial Corp grew its stake in shares of HealthEquity by 58.2% in the 4th quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock valued at $119,831,000 after buying an additional 664,979 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insiders Place Their Bets

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the transaction, the insider now owns 89,769 shares in the company, valued at $7,168,952.34. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Frank Corvino sold 7,705 shares of HealthEquity stock in a transaction dated Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the sale, the director now directly owns 6,070 shares in the company, valued at $497,072.30. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the sale, the insider now owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The disclosure for this sale can be found here. Over the last quarter, insiders sold 77,511 shares of company stock worth $6,314,446. Insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

HQY has been the topic of several recent analyst reports. Wells Fargo & Company upped their price objective on shares of HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a report on Thursday, June 20th. Bank of America reiterated a “buy” rating and set a $105.00 target price on shares of HealthEquity in a report on Wednesday, July 3rd. Raymond James increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. Barrington Research increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, June 4th. Finally, KeyCorp increased their target price on shares of HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $101.67.

HealthEquity Stock Performance

Shares of HQY stock traded down $6.46 during mid-day trading on Friday, hitting $71.41. The stock had a trading volume of 1,346,246 shares, compared to its average volume of 727,150. HealthEquity, Inc. has a fifty-two week low of $61.81 and a fifty-two week high of $88.26. The firm has a market cap of $6.21 billion, a PE ratio of 77.62, a PEG ratio of 1.31 and a beta of 0.57. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.39 and a quick ratio of 4.39. The company’s 50-day simple moving average is $81.22 and its 200-day simple moving average is $80.15.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, June 3rd. The company reported $0.55 EPS for the quarter, beating the consensus estimate of $0.47 by $0.08. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. The firm had revenue of $287.60 million during the quarter, compared to analysts’ expectations of $278.78 million. Sell-side analysts anticipate that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.